A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610

Japanese Journal of Clinical Oncology
Hiroshi UrakawaToshifumi Ozaki

Abstract

A randomized phase III trial was planned to commence in October 2017. Resectable giant cell tumor of bone (GCTB) without possible postoperative large bone defect has been treated by curettage with local adjuvant treatment, with the local recurrence rate found to be as high as 24.6-30.8%. The aim of this study is to confirm the superiority of preoperative denosumab for patients with GCTB without possible postoperative large bone defect. A total of 106 patients will be accrued from 34 Japanese institutions over 5 years. The primary endpoint is relapse-free survival (RFS). Secondary endpoints include overall survival, joint-preserved survival, local RFS, metastasis-free survival, adverse events, serious adverse events, surgical and postoperative complications, and discontinuation of denosumab. This trial is conducted by the Bone and Soft Tissue Tumor Study Group in the Japan Clinical Oncology Group and has been registered in the UMIN Clinical Trials Registry as UMIN000029451 [http://www.umin.ac.jp/ctr/index.htm].

References

Feb 14, 1998·The Journal of Bone and Joint Surgery. British Volume·K A SiebenrockM G Rock
Oct 20, 1998·Pathology International·F MasuiK Fujii
Mar 7, 2008·Journal of Cancer Research and Clinical Oncology·Maurice BalkeGeorg Gosheger
May 3, 2008·The Journal of Bone and Joint Surgery. American Volume·UNKNOWN Arbeitsgemeinschaft KnochentumorenPer-Ulf Tunn
Feb 13, 2010·The Lancet Oncology·David ThomasSusie Jun
Feb 9, 2011·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Akihiko TakeuchiYong-Koo Kang
Feb 22, 2011·Journal of Surgical Oncology·Akihiko MatsumineUNKNOWN Japanese Musculoskeletal Oncology Group
Dec 14, 2011·The Journal of Bone and Joint Surgery. British Volume·C L GastonR J Grimer
Jun 20, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel G BranstetterIra Jacobs
Jul 28, 2013·Reproductive Toxicology·Jeanine L BussiereGary Chellman
Mar 7, 2014·The Journal of Bone and Joint Surgery. American Volume·Lizz van der HeijdenP D Sander Dijkstra
Aug 8, 2014·The Journal of Bone and Joint Surgery. American Volume·Isabella W Y MakMichelle Ghert
Jul 25, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T UedaT Yoneda
Mar 19, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Frank TraubJay S Wunder
Apr 14, 2016·Oncology Letters·Naohisa FutamuraYoshihiro Nishida

❮ Previous
Next ❯

Citations

May 27, 2020·Current Opinion in Oncology·Lizz van der HeijdenHans Gelderblom
May 14, 2020·Clinical Orthopaedics and Related Research·Suraj HindiskerePramod S Chinder
Apr 14, 2020·Journal of Orthopaedics·Daniel T MilesThomas J Scharschmidt
Oct 24, 2020·International Orthopaedics·Gennady N Machak, Andrey I Snetkov
Oct 31, 2020·Frontiers in Oncology·Hengyuan LiZhaoming Ye
Feb 23, 2021·Current Osteoporosis Reports·Kristen S Pan, Alison M Boyce
Aug 8, 2021·Cancers·Shinji TsukamotoCostantino Errani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Japanese Journal of Clinical Oncology
Tomoyuki HishidaLung Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG-LCSSG)
© 2022 Meta ULC. All rights reserved